Pre-Merger Deal Prompts Pharma Co. Derivative Suit In Del.
An Ayala Pharmaceuticals stockholder has launched a derivative suit against the company's board and controlling investors in Delaware's Court of Chancery, accusing directors of issuing new shares to the controllers at...To view the full article, register now.
Already a subscriber? Click here to view full article